DCB for In-stent Restenosis: Is It Superior to DES? - Robert Byrne, MB BCh, PhD

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - DCB Technology Symposium - Coronary

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

DCB for In-stent Restenosis: Is It Superior to DES? presented by Robert Byrne, MB BCh, PhD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: DCB Technology Symposium - Coronary

Track: Technology & Innovation

Learning Objectives

  • Update in advances with bioresorbable & DCB technologies in interventional procedures

Other Components in this Moment

Overview
DCB for In-stent Restenosis: Is It Superior to DES? - Robert Byrne, MB BCh, PhD
Is There Any Role of DCB for the Treatment of De Novo Lesions? - Juan Granada, MD
DCB as Adjunct Therapy to DES and BRS - Azeem Latib, MD
DCB for Coronary Intervention: State of the Field and Where are we Going From Here? - Bruno Scheller, MD
Loading Simple Education